This inventor holds 1 USPTO granted patent. Top assignee: Kobe University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Naoto Kunimura: Innovator in Cancer Gene Therapy
Introduction
Naoto Kunimura is a prominent inventor based in Hyogo, Japan. He has made significant contributions to the field of cancer research, particularly in the development of gene therapy drugs. His innovative approach aims to provide novel therapeutic means for cancer treatment.
Latest Patents
Kunimura holds a patent for a cancer gene therapy drug. This patent describes a nucleic acid structure that includes three components: (A) a nucleic acid encoding a protein with a CD44 extracellular function, (B) a nucleic acid encoding a protein with a Notch core region function, and (C) a nucleic acid encoding a protein with an HIF-3α4 function. This unique combination is designed to enhance the effectiveness of cancer treatment.
Career Highlights
Kunimura is affiliated with Kobe University, where he conducts research and develops innovative solutions in the field of cancer therapy. His work has garnered attention for its potential to improve patient outcomes through advanced gene therapy techniques.
Collaborations
He collaborates with notable colleagues, including Toshiro Shirakawa and Koichi Kitagawa. Their combined expertise contributes to the advancement of research in cancer gene therapy.
Conclusion
Naoto Kunimura's contributions to cancer gene therapy exemplify the impact of innovative research in medicine. His work continues to pave the way for new therapeutic options in the fight against cancer.